About Index Trending news
Analyze
Top 50 Pricing
Targovax

Targovax

Work at Targovax? Add yourself to this profile

Targovax

Targovax develops active immunotherapy in the form of cancer vaccines forapplication in post-operation treatments.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding
Venture capital (Series B)
$13,300,000
Venture capital (Series A)
$3,600,000
Employees

Team size

10+
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Targovax makes some noise.